Section Arrow
Quote
IART.NASDAQ
- Integra LifeSciences Holdings Corp
Quotes are at least 15-min delayed:2026/03/10 01:07 EDT
Regular Hours
Last
 9.57
-0.16 (-1.64%)
Day High 
9.67 
Prev. Close
9.73 
1-M High
12.375 
Volume 
1.11M 
Bid
9.5
Ask
9.74
Day Low
9.17 
Open
9.475 
1-M Low
9.365 
Market Cap 
758.33M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 10.86 
20-SMA 11.14 
50-SMA 11.75 
52-W High 24.365 
52-W Low 9.365 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.74/2.34
Enterprise Value
2.65B
Balance Sheet
Book Value Per Share
13.39
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
1.64B
Operating Revenue Per Share
19.79
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.65+3.09+2.82%29.21PE
BSXBoston Scientific Corp71.9+0.55+0.77%36.78PE
MDTMedtronic plc91.34+0.44+0.48%25.39PE
BFLYButterfly Network3.76+0.11+3.01%-- 
PACBPacific Biosciences of California1.39+0.01+0.72%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.